Broken redirects

Jump to navigation Jump to search

The following redirects link to non-existent pages:

Showing below up to 50 results in range #751 to #800.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. NUT-2Efficacy Assessment Of Meloxicam, A Preferential Cyclooxygenase-2 Inhibitor, In Acute Coronary Syndromes Without St-Segment Elevation. The Nonsteroidal Anti-Inflammatory Drugs In Unstable Angina Treatment-2 (Nut-2) Pilot Study
  2. F.I.R.E.Efficacy Of Fx06 In The Prevention Of Myocardial Reperfusion Injury Trial
  3. TIMICEfficacy Of Immunosuppressive Therapy In Patients With Virus-Negative Inflammatory Cardiomyopathy
  4. RISEfficacy Of Multiple Risk Factor Intervention In Treated Hypertensive Men
  5. ERICAEfficacy Of Ranolazine In Chronic Angina
  6. EVERESTEfficacy Of Vasopressin Antagonism In Heart Failure: Outcome Study With Tolvaptan
  7. Eisenmenger’s SyndromeEisenmenger’s Complex
  8. EFICATEjection Fraction In Cardiac Transplant Patients
  9. EPOSElective Pci In Outpatient Study
  10. Electrical chargeElectric charge
  11. ChargedElectric charge
  12. ElectricalElectric charge
  13. PositiveElectric charge
  14. Positive chargeElectric charge
  15. AVID Electrical Storm SubstudyElectrical Storm Presages Nonsudden Death. The Antiarrhythmics Vs. Implantable Defibrillators (Avid) Trial
  16. User:Amber24paigeElectronic cigarette 24
  17. ESVEMElectrophysiologic Study Versus Electrocardiographic Monitoring Trial
  18. Eli LillyEli Lilly and Company
  19. Elias CoreyElias James Corey
  20. E.J. CoreyElias James Corey
  21. Elixir SulfanilamideElixir Sulfanilamide disaster
  22. ED-IMPACTEmergency Department Impedance Cardiography-Aided Assessment Changes Therapy Sponsor: Cardiodynamics International
  23. EMTALAEmergency Medical Treatment and Active Labor Act
  24. Emil von BehringEmil Adolf von Behring
  25. EASTEmory Angioplasty Vs Surgery Trial
  26. Empty caloriesEmpty calorie
  27. DIG EnalaprilEnalapril Versus Digoxin In Patients With Congestive Heart Failure: A Multicenter Study (Canadian Enalapril Versus Digoxin Study Group)
  28. TulvingEndel Tulving
  29. Duke criteriaEndocarditis diagnosis#Duke Clinical Criteria for the Diagnosis of Infective Endocarditis
  30. Modified Duke CriteriaEndocarditis diagnosis#Duke Clinical Criteria for the Diagnosis of Infective Endocarditis
  31. Modified duke criteriaEndocarditis diagnosis#Duke Clinical Criteria for the Diagnosis of Infective Endocarditis
  32. Modified Duke criteriaEndocarditis diagnosis#Duke Clinical Criteria for the Diagnosis of Infective Endocarditis
  33. ECRISEndocoronary-Rhenium-Irradiation-Study
  34. MATHEndocrine And Renal Effects Of Nifedipine Gastrointestinal Theraputic System In Patients With Essential Hypertension: Results Of A Multicenter Trial
  35. Benign endometrial hyperplasiaEndometrial hyperpasia
  36. EARTHEndothelin Receptor Antagonist Trial In Heart Failure
  37. EVEREST IEndovascular Valve Edge-To-Edge Repair Study
  38. CAVATASEndovascular Versus Surgical Treatment In Patients With Carotid Stenosis In The Carotid And Vertebral Artery Transluminal Angioplasty Study (Cavatas)
  39. EF5Enhanced Fujita Scale
  40. ESPRITEnhanced Suppression Of The Platelet IIb/IIia Receptor With Integrilin TherapyEuropean Study Of The Prevention Of Reocclusion After Initial ThrombolysisEvaluation Of Subcutaneous Proleukin In A Randomized International Trial
  41. ENRICHDEnhancing Recovery In Coronary Heart Disease
  42. ExTRACTEnoxaparin And Thrombolysis Reperfusion For Acute Myocardial Infarction Treatment
  43. ENTIREEnoxaparin And Tnk-Tpa With Or Without Gp IIb/IIia Inhibitor As Reperfusion Strategy In St Elevation Mi (TIMI-23)
  44. EVETEnoxaparin Versus Tinzaparin In Non-St-Segment Elevation Acute Coronary Syndromes
  45. ENCOREnrasentan Cooperative Randomized Evaluation
  46. ECLIPSEEnsure's Vascular Closure Device Speeds Hemostasis Trial
  47. EnvironmentalistEnvironmentalism
  48. Epigastric arteriesEpigastric artery
  49. EponymsEponym
  50. EVA-AMIEptifibatide Versus Abciximab In Primary Pci For Acute St Elevation Myocardial Infarction

View ( | ) (20 | 50 | 100 | 250 | 500)